Gallen Expert Panel recommends classifying the intrinsic molecular subtypes using immunohistochemistry (IHC) markers as surrogates: oestrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2), and the proliferation marker Ki-67 or tumour grade13. The gene discussed is PGR; the disease is neoplasm.